FDA Advisory No. 2017-262
Public Health Warning Against the following Unregistered Food Supplements with their Corresponding Unapproved and Misleading Advertisements and Promotion:
The Food and Drug Administration (FDA) advises the public against the purchase and consumption of the following unregistered food supplements:
1. HEALTH AND NATURALS COLLECTION
2. MILK THISTLE (SILYMARIN) FOOD SUPPLEMENT
3. NEW DOK-APO DETOX CLEANSING FOOD SUPPLEMENT
The public is hereby warned that the food products and food supplements are not registered with the FDA. Pursuant to Republic Act No. 9711, otherwise known as the “Food and Drug Administration Act of 2009”, the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising or sponsorship of health products without the proper authorization from FDA is prohibited.
Likewise, all claims in the advertisements are unapproved and misleading. As per a
Administrative Order 2010-0008, no person shall advertise, promote, or use in any sponsorship any food/dietary supplements unless such product is duly registered and approved by the Food and Drug Administration.
Accordingly, since unregistered food products and food supplements have not gone through evaluation and testing process of the FDA, the agency cannot guarantee their quality and safety. The consumption of such violative products may pose potential health hazards to the consuming public. Food products including food supplements should not bear any misleading, deceptive, and false claims in their labels and/or any promotional materials that will provide erroneous impression on products’ character or identity.
In light of the above, the public is advised not to purchase the aforementioned violative product. Moreover, the public is advised to be vigilant against food products that might not be duly registered with FDA. Always check if a food product has been registered with FDA before purchasing it by making use of the embedded Search feature of the FDA website accessible at www.fda.gov.ph.
Dissemination of the information to all concerned is requested.